ALR Technologies SG (ALRTF) Receivables (2023)
ALR Technologies SG (ALRTF) posted Receivables of $41100.0 for Q4 2023, down 77.82% on a QoQ basis from $185285.0 in Q2 2023.
ALR Technologies SG (ALRTF) Receivables (2023) Analysis & Trends
ALR Technologies SG's Receivables history runs 1 years deep, the most recent figure standing at $41100.0 for Q4 2023.
- Quarterly Receivables changed N/A year-over-year to $41100.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $41100.0 (changed N/A YoY) and the FY2023 annual result came in at $41100.0, changed N/A from the prior year.
- Receivables was $41100.0 for Q4 2023 at ALR Technologies SG, down from $185285.0 in the prior quarter.
- Across five years, Receivables topped out at $185285.0 in Q2 2023 and bottomed at $41100.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.11 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.80 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.55 Bn |
| 10 | ALR Technologies SG | 61.20 Mn | 61.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 41,100.00 |
| Jun 30, 2023 | 185,285.00 |